Inappropriate sinus tachycardia treatment guidelines
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
ACC/AHA/ESC Practice Guidelines. Recommendations for Treatment of Inappropriate Sinus Tachycardia[1] (DO NOT EDIT)
| “ |
Medical1) Beta blockers (Level of Evidence: C) 1) Verapamil, diltiazem (Level of Evidence: C) Interventional1) Catheter ablation-sinus node modification/elimination (Used as a last resort) (Level of Evidence: C)
|
” |
References
- ↑ Blomström-Lundqvist C, Scheinman MM, Aliot EM, Alpert JS, Calkins H, Camm AJ, Campbell WB, Haines DE, Kuck KH, Lerman BB, Miller DD, Shaeffer CW, Stevenson WG, Tomaselli GF, Antman EM, Smith SC, Alpert JS, Faxon DP, Fuster V, Gibbons RJ, Gregoratos G, Hiratzka LF, Hunt SA, Jacobs AK, Russell RO, Priori SG, Blanc JJ, Budaj A, Burgos EF, Cowie M, Deckers JW, Garcia MA, Klein WW, Lekakis J, Lindahl B, Mazzotta G, Morais JC, Oto A, Smiseth O, Trappe HJ (2003). “ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias–executive summary. a report of the American college of cardiology/American heart association task force on practice guidelines and the European society of cardiology committee for practice guidelines (writing committee to develop guidelines for the management of patients with supraventricular arrhythmias) developed in collaboration with NASPE-Heart Rhythm Society”. Journal of the American College of Cardiology. 42 (8): 1493–531. PMID 14563598. Retrieved 2012-09-12. Unknown parameter
|month=ignored (help)
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH
